Click here to read the articles and download the PDF

Pharmaceutical Commerce - December 2024

Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.

Did Industry Fumble the DSCSA Deadline?

A crash course on the bubble itself, including therapeutic areas most affected.

Going Inside the Gross-to-Net Bubble and Its Nuances

Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.

Why AI Advances in CGT Require Getting Data Right

Articles

The latest in container tech and temperature-monitoring truly powered the content. 

Popular DSCSA Pieces Throughout the Year

The latest news for pharma industry insiders.

Pharma Pulse 12/24/24: How Telehealth and Pharma are Partnering to Revolutionize Healthcare, The Influence of Vaping on Smoking Cessation & more

Jon Hamrick, partner, Curatio Scientia Advisors, discusses upcoming industry challenges at this year's Trade & Channel Strategies Conference in Philadelphia. 

Trade & Channel Strategies 2024: Navigating Industry Challenges

How will supply chains in the space continue to develop?

Forecasting the 2025 Healthcare Logistics Space

Pharma Pulse 12/23/24: Impact of DEA Telehealth Extensions, Big Jump in US Healthcare Spending & more

Videos

Bill Trombetta, PhD, professor, healthcare strategy, marketing, St. Joseph's University, discusses the difference between return on invested capital in pharma compared to other organizations. 

Trade & Channel Strategies 2024: The Significance of Return on Invested Capital for Pharma Companies

In the fifth part of this roundtable discussion, subject matter experts discuss the role that various GS1 initiatives have played, and provide a breakdown of stakeholders who have benefitted greatly from RFID.

Peer Exchange: The Impact of RAIN RFID (Episode 5)

As a result, the provider increases its involvement in the country’s pharma sector. 

Featured Content

Pharmaceutical Commerce - December 2024

Did Industry Fumble the DSCSA Deadline?

Going Inside the Gross-to-Net Bubble and Its Nuances

Why AI Advances in CGT Require Getting Data Right